Cargando…

Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson’s Disease

Alterations in mitochondrial function and morphology are associated with many human diseases, including cancer and neurodegenerative diseases. Mitochondrial impairment is linked to Parkinson’s disease (PD) pathogenesis, and alterations in mitochondrial dynamics are seen in PD models. In particular,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Portz, Philipp, Lee, Michael K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070398/ https://www.ncbi.nlm.nih.gov/pubmed/33924585 http://dx.doi.org/10.3390/cells10040885

Ejemplares similares

Developmental Changes in Dendritic Spine Morphology in the Striatum and Their Alteration in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Parajuli, Laxmi Kumar, et al.
Publicado: (2020)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
por: Zaltieri, Michela, et al.
Publicado: (2015)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

Differential mitochondrial roles for α-synuclein in DRP1-dependent fission and PINK1/Parkin-mediated oxidation
por: Krzystek, Thomas J., et al.
Publicado: (2021)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease
por: Yang, Yunseon, et al.
Publicado: (2022)

Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson’s disease
por: Yan, Mingmin, et al.
Publicado: (2022)

Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson’s disease associated with enhanced autophagy
por: Wan, Tengfei, et al.
Publicado: (2021)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease
por: Zhou, Wenbo, et al.
Publicado: (2017)

Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease
por: Brembati, Viviana, et al.
Publicado: (2023)

Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
por: Raiss, Christian C., et al.
Publicado: (2016)

The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease
por: Meng, Lanxia, et al.
Publicado: (2023)

CaM kinase Iα–induced phosphorylation of Drp1 regulates mitochondrial morphology
por: Han, Xiao-Jian, et al.
Publicado: (2008)

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
por: Lloyd, Grace M., et al.
Publicado: (2023)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
por: Wang, Rui, et al.
Publicado: (2022)

Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
por: Pozo Devoto, Victorio M., et al.
Publicado: (2017)

Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease
por: Wills, Jonathan, et al.
Publicado: (2011)

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain
por: Cronin, Kenneth D., et al.
Publicado: (2009)

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s disease
por: Yan, Yaping, et al.
Publicado: (2021)

Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson’s Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology
por: Diao, Xiaojun, et al.
Publicado: (2021)

D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
por: Kim, Donghoon, et al.
Publicado: (2018)

Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
por: Dhillon, Jess-Karan S., et al.
Publicado: (2019)

No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models
por: Sastry, Namratha, et al.
Publicado: (2015)

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis
por: van den Berge, Simone A., et al.
Publicado: (2012)

Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
por: Yuan, Xin, et al.
Publicado: (2022)

Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies
por: Price, Diana L., et al.
Publicado: (2016)

Environmental Enrichment Attenuates Oxidative Stress and Alters Detoxifying Enzymes in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Seo, Jung Hwa, et al.
Publicado: (2020)

Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains
por: Grigoletto, Jessica, et al.
Publicado: (2022)

Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
por: Rutherford, Nicola J., et al.
Publicado: (2015)

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
por: Chatterjee, Diptaman, et al.
Publicado: (2018)

αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?
por: Protter, David, et al.
Publicado: (2012)

Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition
por: Fan, Rebecca Z., et al.
Publicado: (2019)

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
por: Chen, Xi, et al.
Publicado: (2015)

Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
por: Argyrofthalmidou, Maria, et al.
Publicado: (2021)

α-Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models
por: Cheng, Jingjing, et al.
Publicado: (2018)

Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease
por: Chen, Qian-Qian, et al.
Publicado: (2018)

A New Synuclein-Transgenic Mouse Model for Early Parkinson’s Reveals Molecular Features of Preclinical Disease
por: Hendrickx, Diana M., et al.
Publicado: (2020)

Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
por: Amschl, David, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i1tlofodc3lqv84p83o9is7enu